Bio Pharma Dive
JANUARY 26, 2021
The French drugmaker, having hit delays with its own coronavirus shot, agreed to manufacture over 100 million doses of Pfizer and BioNTech's vaccine for supply in Europe.
World of DTC Marketing
JANUARY 26, 2021
SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready? It’s a question that I ask all of my clients at a time when more people are going online for health information. But let’s start at the beginning… 1ne: What’s the purpose of your product website?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 26, 2021
Results from the large Phase 3 trial are highly anticipated. If proven effective, J&J's shot could provide much-needed reinforcements to a constrained immunization effort.
Pharma Mirror
JANUARY 26, 2021
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the leading cause of death worldwide, with 18 million deaths each year according to World Health Organization estimates.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 26, 2021
The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high.
Pharma Mirror
JANUARY 26, 2021
Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is particularly difficult in the case of cardiovascular disease, which remains the leading cause of death worldwide, with 18 million deaths each year according to World Health Organization estimates.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Mirror
JANUARY 26, 2021
Navigating your way to a career in the medical field is not easy. You may have spent late nights studying for exams and long hours working in a medical institute. But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.
NY Times
JANUARY 26, 2021
President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.
BioPharma Reporter
JANUARY 26, 2021
AstraZeneca along with its scientific partners at the University of Oxford have rejected German media reports that their vaccine against COVID-19 had low efficacy in people aged over 65.
BioSpace
JANUARY 26, 2021
Police have sealed off the area, according to the report. Few details were available, but eye witnesses said a robot was investigating a suspicious package found at the plant.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JANUARY 26, 2021
Novartis has said that its investment in digital technology has helped it to ride out the worst of the pandemic, although sales of some of its newly-launched products have been affected by a fall in prescriptions and hospital visits. The big Swiss pharma still managed to grow sales in Q4 compared with the same period last year, with sales increasing a reported 3% to $12.8 billion and profits growing 2% to just over $3 billion.
BioSpace
JANUARY 26, 2021
At the annual J.P. Morgan conference, the biotech industry launched its encore to a wildly successful 2020 – virtually. And, as is becoming the common scenario, attendees found both pros and cons to our new (temporary?) reality.
pharmaphorum
JANUARY 26, 2021
Governments must act to restore the damage done to lung cancer services during the pandemic in order to reduce further avoidable deaths, according to a report drawn up as part of this week’s World Economic Forum in Davos. The report , Learning Lessons from Across Europe – Prioritising Lung Cancer after COVID-19, highlights how lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely, the longer the pandemic continues.
BioSpace
JANUARY 26, 2021
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca for the last few months has been on their COVID-19 vaccine efforts.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioPharma Reporter
JANUARY 26, 2021
Advice published by the World Health Organization today says the two doses of the Moderna vaccine should be administered 28 days apart; but this interval can be extended up to 42 days if necessary.
BioSpace
JANUARY 26, 2021
Vir Biotechnology, Eli Lilly and GlaxoSmithKline struck a three-way collaborative deal to evaluate its investigational monoclonal antibody, VIR-7831, in combination with Lilly’s bamlanivimab in low-risk patients with mild to moderate COVID-19.
BioPharma Reporter
JANUARY 26, 2021
EU health commissioner, Stella Kyriakides, last night again expressed dissatisfaction with the responses the EU executive has received from AstraZeneca over the company's announcement there would be significant shortfalls in the supply of its COVID-19 vaccine to the EU.
BioSpace
JANUARY 26, 2021
The Series A financing will help fuel Nuvalent’s research and development efforts for a portfolio of innovative small molecule kinase inhibitors for programs in non-small cell lung cancer.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
JANUARY 26, 2021
Native people lived in flammable landscapes of the American West for millenia Credit: Christopher Roos DALLAS (SMU) – Wildfires are the enemy when they threaten homes in California and elsewhere. But a new study led by SMU suggests that people living in fire-prone places can learn to manage fire as an ally to prevent dangerous […].
BioSpace
JANUARY 26, 2021
See the companies featured in our 2021 maps, explore the territories that are thriving in the life sciences industry, research leading employers and search for relevant jobs on BioSpace.
Scienmag
JANUARY 26, 2021
Credit: Everton Miranda/University of KwaZulu?Natal Harpy eagles are considered by many to be among the planet’s most spectacular birds. They are also among its most elusive, generally avoiding areas disturbed by human activity – therefore already having vanished from portions of its range – and listed by the International Union for the Conservation of Nature […].
BioSpace
JANUARY 26, 2021
On Tuesday, the U.K. offered its genomics expertise to identify emerging variants of the SARS-CoV-2 virus to countries that lack the resources to make such identifications.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
JANUARY 26, 2021
Credit: Creative Commons via Upsplash Michigan State University researchers have received a $3.8 million grant from the National Institute of Child Health and Development to advance research on the effects of prenatal and postnatal stress on child psychopathology. The Prenatal Stress Study, which first began in 2016, is the first study of its kind. The […].
Pharma Times
JANUARY 26, 2021
Lab tests evaluated vaccine's efficacy against UK and South African variants
Scienmag
JANUARY 26, 2021
Credit: Earth Leadership Program BOULDER, CO: In the midst of cascading crises from climate change to biodiversity loss and the ongoing COVID-19 pandemic, the Earth Leadership Program – the global successor to the renowned Leopold Leadership Program, now in partnership with Future Earth – has announced its 2021-22 North American cohort. The Earth Leadership Program […].
BioSpace
JANUARY 26, 2021
Pfizer announced in a statement on Wednesday that the prespecified non-inferiority criteria for a post-marketing safety study of rheumatoid arthritis (RA) drug XELJANZ® (tofacitinib) were not met.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
JANUARY 26, 2021
Experiencing Artificial Intelligence through humanoid robots: Focus on exchange between society and research Credit: KIT Artificial intelligence, AI for short, is subject of imagination, films, and stories, but it also is reality. Superhuman capacity of AI is obvious in games as well as in image and language processing, in autonomous driving, in digital language assistants, […].
Outsourcing Pharma
JANUARY 26, 2021
While the change signifies the life-sciences solutions firmâs commitment to help customers and patients, day-to-day functions will remain much the same.
Scienmag
JANUARY 26, 2021
Dogs can learn new words after hearing them only four times Credit: Photo by Claudia Fugazza A new study found that talented dogs can learn new words after hearing them only four times. While preliminary evidence seems to show that most dogs do not learn words (i.e. names of objects), unless eventually very extensively trained, […].
Pharma Times
JANUARY 26, 2021
Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
355 
Let's personalize your content